Prot #NU MSK19H03: A Phase II Study of Pembrolizumab and Entinostat in Patients with Relapsed and Refractory Lymphomas (17-073)

Project: Research project

Project Details

StatusActive
Effective start/end date9/17/209/17/23

Funding

  • Memorial Sloan-Kettering Cancer Center (Prot #NU MSK19H03)